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Abstract: 
 The chicken anemia virus protein Apoptin is able to selectively induce apoptosis in 
transformed cells while leaving primary cells intact. The mechanism of this selection is currently 
unknown. The product of the third open reading frame of PCV2 has a high degree of homology 
with the chicken anemia virus protein Apoptin, and has two naturally-occurring isoform, PCV2a 
and PCV2b. PCV2b displays dramatically higher apoptotic ability over PCV2a, despite the high 
degree of homology between the two; there is a difference of only two amino acids between 
PCV2b and PCV2a. To determine the role of the two different amino acids in the induction of 
apoptosis, a chimeric protein was generated featuring one distinct amino acid from each isoform. 
Using a caspase apoptosis assay, apoptotic ability of this chimeric protein was assessed. A 
clearer understanding of the functionality and apoptotic mechanisms of these proteins in 
transformed cells may lead to therapeutic applications for cancer. 
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Introduction: 
 
Porcine circovirus type 2 (PCV2) is a virus of the family Circoviridae. Circoviridae are a 
family of viruses that are characteristically small, about 17-22nm in diameter. These viruses are 
naked icosahedral viruses with circular, single-stranded DNA genomes that code for only one 
capsid protein. Members of Circoviridae are prevalent and fairly stable in the environment. 
Polymerases with repair activity in their host cells use the circovirus ssDNA as the template to 
build the genomes that will compose progeny virions  (1). The forces of viral evolution of the 
family Circoviridae seem to lead back to naturally occurring point mutations and recombination  
(2).  
PCV2 belongs specifically to the Circovirus genus of the Circoviridae family. It is 
commonly found in swine, and is the causative agent for post-weaning multisystemic wasting 
disorder (PWMD  (1). PCV2 consists of an icosahedral protein capsid and a single-stranded 
circular DNA genome consisting of approximately 1.76kb (3). It is non-enveloped and 17nm in 
diameter, both typical features of members of the family Circoviridae. (4). PCV2’s is composed 
of protein coat subunits assembled in 12 pentameric units  (5). The multiple routes for the 
transmission of PCV2 from pig to pig include nasal, oral, and fecal cavities. The virus may be 
present in any excretions or secretions of an infected pig, and is easily spread through entire 
swine groups (6). 
The PCV2 genome consists of six open reading frames, three of which are functional and 
are used to produce four different proteins:  Rep, rep’, capsid, and VP3. Both the rep and rep’ 
proteins form PCV’s replicase complex; these two proteins recognize each other and have been 
shown to interact with each other at the hair-pin loop at the origin of replication, thus initiating 
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replication  (7). The capsid protein forms the protein viral coat. The VP3 protein proves to be 
unique from the other three proteins; it is involved in neither viral genome replication nor 
formation of the viral protein capsid (19). This product of PCV2’s third open reading frame plays 
a central role in inducing cellular apoptosis in its host cells, allowing rapid of spread of progeny 
virions; previous research has proven VP3 necessary for viral pathogenesis (8). 
Two isoforms of PCV2 exist; they are PCV2a and PCV2b. The two isoforms show 
significant homology to one another. Their genomic nucleotide sequences differ by only 5%. 
They both produce the same four proteins of their six open reading frames  (9). Of the two 
isoforms, PCV2b is the virulent isoform associated with the high mortality rates among swine 
through induction of cellular apoptosis; the PCV2a isoform is considered nonpathogenic (10). 
The difference in killing capacity between PCV2a and PCV2b is believed to be a result of two 
point mutations in two putative domains, one of which is the protein's nuclear export sequence 
(located towards the N terminus), and the other is the protein's localization/multimerization 
sequence (featured towards the C terminus) which also contains the phosphorylation site. The 
nonpolar glycine at position 41 of the PCV2a peptide chain is replaced by a polar serine in 
PCV2b, in addition to the replacement of an aromatic phenylalanine at the very end of the 
PCV2a protein with an aliphatic leucine in PCV2b. This difference seems to confer the increased 
apoptotic capacity and subsequent lethality of the “b” isoform (11).  
PCV2’s protein product of its third open reading frame, VP3, demonstrates considerable 
homology to chicken anemia virus (CAV) VP3. CAV VP3, also referred to as Apoptin, has been 
identified as a novel protein with the capacity to induce apoptosis in transformed cells only, 
leaving primary cells intact. The detailed mechanism by which Apoptin selectively causes 
apoptosis has not yet been elucidated, but is widely thought to be due in some part to differential 
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localization of Apoptin: in transformed cells it tends to localize in the nuclear space, and in 
primary cells it localizes in the cytoplasm. The method by which this selective apoptosis takes 
place via Apoptin is thought to be due to the induction of its shuttling between the cytosol and 
nuclear space. Movement of CAV Apoptin out of the nucleus and into the cytoplasm allows its 
interaction with anaphase promoting complex/cyclosome (APC/C) of the host cell. Upon exiting 
the nucleus, Apoptin is able to interact with APC1 leading to inhibition of APC/C. This in turn 
leads to the host cell entering cell cycle block leaving itself trapped in the G2M stage resulting in 
apoptosis (12). This pathway results in p53-independent cell death. In addition to this, it has been 
speculated that apoptotic induction by Apoptin is part of a mitochondrial death pathway. Apoptin 
has been shown to be associated with cytochrome C release from mitochondria which causes 
subsequent caspase 3 and 7 activation and formation of apoptosome. In the process of 
apoptosome formation, cytochrome C interacts with the protein Apf-1 to disable the auto-
inhibition of Apf-1’s WD-40 domain, allowing further quaternary structure formation wherein 
ATP can bind to the structure to disinhibit the CARD domain. Once the CARD domain has been 
exposed, the structure can then complex with caspase 9, whose activity induces the total caspase 
cascade, ultimately inducing apoptosis (13). 
Still, however, the killing ability of Apoptin does not seem to be due solely to nuclear 
localization; the protein is also suspected to have the ability to multimerize, which may play a 
role in its apoptotic ability (13). The primary evidence for this multimerization capability lies in 
the punctate appearance of Apoptin in fluorescence localization studies in which it is conjugated 
with green fluorescent protein. The structural motif responsible for Apoptin’s tendency to 
aggregate into multimers has been mapped to the hydrophobic interactions of the N-terminal half 
of the protein. Apoptin’s globular aggregation is strong and practically irreversible. In addition to 
 8 
 
this, research conducted by Leliveld et.al suggests that Apoptin’s killing capacity does not lie 
within specific secondary structures among the multimer; rather, semi-random aggregation 
seems to be adequate to induce apoptotic activity among host cells (14). 
CAV Apoptin and PCV2 VP3 show considerable degrees of homology. This homology 
between the better-studied Apoptin of avian anemia and PCV2 VP3 is significant, making 
present research regarding of Apoptin useful for a stronger understanding of PCV2 VP3. Prior 
research has indicated that PCV2 VP3 may also selectively induce apoptosis in a similar fashion, 
suspected due to its homology with CAV Apoptin. It is similar to Apoptin in that it is believed to 
be able to mulitmerize with itself, in addition to having a sequence for nuclear export (15).  
VP3 functions in triggering cell death via a p53-dependent pathway. PCV2 VP3 has been 
demonstrated to interact with the porcine ubiquitin protein pPirh2. The ubiquitin pPirh2 has the 
ability to complex p53 and induce its degradation through proteosomic signaling. This yields a 
possible mechanism for PCV2’s killing capacity; by causing an increase in p53 levels through 
inhibition of its ubiquitylation, the apoptotic process is induced. Through yeast-two-hybrid 
experiments as well as localization and co-immunopreciptation studies, a definite physical 
interaction PCV2 VP3 and the p53-binding-domain of Pirh2 was demonstrated. (16). The 
activation of an apoptosis-inducing gene is regulated by phosphorylation of the p53 serine 
residue at position 146. This possible mechanism has been corroborated by studies in which 
PCV-infected and ORF3-transfected cells show increased expression, thus leading to higher 
likelihood of p53 phophorylation and therefore up-regulation of apoptosis (17). 
Additionally, infection with PCV2 appears to differ from Apoptin with regard to its 
activation of the JNK1/2 and p38/MAPK (Mitogen-Activated Protein Kinsae) pathways, which 
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serve to regulate the host cell apoptotic pathway for a wide variety of viruses. Research 
conducted by Liu, et.al led to speculation that phosphorylation of JNK causes p53 to dissociate 
from it. PCV2’s ability to modulate these two cell-signaling pathways depends on PCV2’s 
replication; UV-irradiated PCV2 along with PCV2 in its early infection stages proved unable to 
interact with the aforementioned pathways. Under ample enough replication of the virus, 
however, this activation further enhances expression of p53 and also stabilizes its activity by 
preventing its proteosomal degradation. Enhancing the pPirh2-mediated up-regulation of p53 by 
inhibition of ubiquitylation even further leads drives the host cell to an apoptotic pathway (17).  
In spite of this mechanistic research, previous in-house research has shown that PCV2b 
VP3 also demonstrates functionality in p53-null cell lines, implying that there may be another 
pathway by which PCV2b VP3 induces apoptosis. 
The negative effects of PCV2 provide great incentive for further research on the 
pathogenicity of this virus. Investigation into the mechanistic details of VP3’s apoptotic selection 
is of central interest to this study. The practical focus of the current research was to introduce a 
gain-of-function mutation into PCV2a via two mutually exclusive cloning strategies, site-
directed mutagenesis and ligation cloning. Exploration of the chimera’s killing ability would 
perhaps reveal characteristics of PCV2 responsible for inducing apoptosis in transfected cells. 
  
 10 
 
Materials and Methods: 
 Overlap Extension Polymerase Chain Reaction 
 Pyrococcus furiosus polymerase was used in conjunction with mutagenic primers 
containing the complement of PCV2B's NES amino sequence difference to generate the chimeric 
protein product. DNA stocks of PCV2A were placed in serial dilutions from 50 ng/μL to 6.25 
ng/μL. 2 μL of resuspended forward and reverse primers was added to  DNA in 1 μL Pfu buffer 
with purified Millipore water added to make a total volume of 50 μL. 18 cycles of PCR were run 
at the following temperatures: cycle 1 at 95°C for 30 seconds, cycle 2 at 95°C for 30 seconds, 
cycle 3 at 55°C for 1 minute, cycle 4 at 68°C for 10 minutes (2 minutes * 5 kilobase for total 
plasmid length), repeat cycles 2-4 five times, rest at hold temperature of 4°C for a total of 17 
cycles.  
 Confirmation of PCR Product 
This product was then digested with dpn1 via addition of 1 μL dpn1 to each PCR product 
tube and incubation at 37°C for an hour.  The restriction was then run on an agarose gel, prepared 
by dissolving .45 g of agarose in 50mL of sterile 1x TAE and microwaving for one minute, then 
pouring into gel tank. When the gel solidified, the gel tank was filled with sterile 1x TAE to a 
level slightly below the top of the solidified gel. The wells were filled with restriction mixture 
and the voltage set to 90V. 
 PCR product DNA was then scaled up by mid-sized culture. 3 μL of PCR product was 
pipetted into thawed supercompetent JM109 E.coli.  DNA-membrane complexes were allowed 
to form for 25 minutes while the tubes were on ice. Cultures then transferred into a 42°C bath for 
exactly 60 seconds for a heat-kill to make E.coli membrane more permeable. The eppendorf 
tubes were then transferred into ice for 2 minutes to help the membranes re-form. To aid in 
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recovery, 450 μL of LB media was added to each culture tube and allowed to rotate in an 
incubator-shaker at 37°C for an hour. A mixture of recovery media with the antibiotic kanamycin 
was prepared by adding 500 μL of 1000x kanamycin into 500 mL of autoclaved LB media. The 
recovered cultures were pipetted into 150 μL LB with kanamycin in autoclaved 500mL 
erlenmeyer flasks and allowed to proliferate overnight in the incubator-shaker at 37°C and 220 
revolutions per minute. 
 Midiprep of cultures was performed using Promega Wizard Midiprep Kit. 100 mL of 
cells in each tube were pelleted at 10,000 x g for 10 minutes at 4°C. The supernatants were 
removed and the pellets were re-suspended in 3 mL of Cell Resuspension Solution. 3 mL of Cell 
Lysis Solution was added to each tube and inverted to mix. Next, 3 mL of Neutralization 
Solution was added and tubes were again inverted to mix. The tubes were centrifuged at 14,000 x 
g for 15 min. at 4°C and the supernatant containing DNA was recovered and transferred to new 
tubes. Purification Resin (10 mL) was added to each tube and mixed by swirling. Using the 
Midicolumn and vacuum, the DNA/Resin mixture was pushed through the column. 15 mL of 
Column Wash Solution with ethanol was also pushed through the column two separate times and 
the pellet was allowed to vacuum dry for 30 sec. after all the liquid had left the column. The 
column was then removed, placed in an eppendorf tube, and then centrifuged for 2 min. at 
10,000 x g. The column was placed in a new eppendorf tube and 300 μL of prewarmed (~70° C) 
ddH2O was added and allowed to sit for 1 min. After, the tubes were centrifuged for 20 sec. at 
10,000 x g to elute the DNA. The Midicolumns were then discarded and the eppendorf tubes 
were centrifuged again, this time at 10,000 x g for 5 min. to pellet the resin. The supernatants 
were collected and transferred to new tubes, resuspended in 50 μL of TE and stored at -20° C.  
 A standard restriction profile was performed by adding 1 μL Buffer C, 1 μL Buffer H, 1 
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μL PCV2a or PCV2b DNA, 1 μL SacII restriction enzyme, and 1 μL EcoRI restriction enzyme in 
the order presented. Two controls lacking one restriction enzyme each were created using PCV2a 
DNA to ensure thorough restriction profiling. These restrictions were allowed to incubate in a 
37°C water bath for an hour. A gel of these restrictions was run in the manner described 
previously. 
 Transfection of H1299 Cell Line 
 A 96-well plate was colonized with H1299 cells. H1299 non-small lung cell carcinoma 
cells were transfected using the Qiagen Effectene Transfection protocol using a variety of PCV2 
VP3 constructs. The first and second wells were transfected with the wild type A and B PCV2 
VP3 isoforms. Subsequently, the third and fourth sets of wells were transfected with the NES 
and NLS truncation mutant constructs of the PCV2A isoform.The final column of wells was 
transfected with our chimeric PCV2A-B VP3 protein. Each transfection was performed in 
quintuplicate. The transfected H1299 cells were incubated in the standard conditions growth 
conditions of 37°C and 5% CO2 in Dulbecco’s Modified Eagle’s Medium (DMEM) with 10% 
fetal bovine serum (FBS) and PSF as an antibiotic (containing penicillin, streptomycin, and 
fungizone). Construct DNAs were combined with 150 μL Buffer EC. 4 μL of Enhancer was 
added to each and the mixtures were mixed by hand. These were incubated at room temperature 
for 5-10 minutes. Approximately 170 μL of the media was removed from each well, and 30 μL 
of the transfection complexes were added dropwise. These transfections were then incubated 
under the standard cellular proliferation conditions for 48 hours. 
 Apoptosis Assay 
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 The Apo-ONE® Homogenous Caspase-3/7 Assay from Promega was used to detect 
caspase enzyme activity. The caspase assay reagents were added in to transfected cells in 
triplicate. 50 μL of Apo-ONE Caspase-3/7 Reagent was added to each well. After 36 hours of 
incubation, the fluorescence emitted from each well was measured using a fluorescence 
spectrometer with an excitation wavelength of 488 nm and a maximum emission wavelength of 
520nm. 
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Results 
Chimeric Protein Generated 
 
 The circovirus protein PCV2B VP3's ability to induce apoptosis in transformed cells is of 
particular interest as a result of PCV2A VP3's high degree of homology and lack of apoptotic 
function (Figure 1). The discrepancies between PCV2a and PCV2b that are of interest are 
located in the putative NES and NLS (Figure 3). This functionally results in a difference of a 
glycine to serine at position 41 and a phenylalanine to leucine at position 96. In an attempt to 
isolate the amino acid difference which may confer killing ability, two mutually exclusive 
methods were used to attempt to generate a chimera of the two PCV2 VP3 proteins with the NES 
of one protein and the NLS of the other. 
Restriction digestion and ligation was selected as a method due to its conceptual 
simplicity (Figure 3). This process will be used to isolate fragments of each isoform of the NLS 
from the GFP vector and remainder of the gene (Figure 3) so that the NLS fragments can be re-
annealed to the opposite vector. The gene will be cleaved approximately 180 bases from the start 
of the gene by SacII and  the terminus by EcoRI. 
 Restriction digestion of both GFP PCV2 VP3 constructs yielded a vector approximately 
4.7 kilobases in length and an insert of approximately 130 base pairs (Figure 4), indicating a 
successful digest at the SacII and EcoRI restriction sites. Restriction digestion and ligation 
protocol to generate the mutants is ongoing. 
 Site-directed mutagenesis via overlap-extension PCR was selected as an additional 
method to generate the mutant due to its efficiency, ease of confirmation of success, and the low 
level of DNA manipulation required, lessening chances of contamination and subsequent 
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degradation of the DNA with nucleases. For the PCR polymerase, Pyrococcus furiosus was 
selected for its processivity, efficiency, and 3'-to-5' exonuclease proofreading activity. 
Utilizing this technique, mutagenic primers containing the complement of the mutation to 
be imposed were synthesized (Figure 5) and annealed to plasmids which have been melted apart 
by heat. The temperature was briefly lowered for Pfu polymerase to extend both primers 
completely around the plasmid (Figure 9), creating a full complement to the melted strand which 
includes the mutation. The process of melting apart and extending fragments of the plasmid was 
repeated for 18 cycles to generate many copies of the mutated plasmid. Following PCR, the 
product of the reaction was treated with dpn1 (Figure 6), a restriction endonuclease which 
recognizes and degrades a short sequence within the plasmid only if it has been methylated. 
Methylation of DNA occurs in E.coli as a way to reduce exogenous plasmid expression and also 
to differentiate between template and daughter DNA. As a result of the template DNA having 
been generated by a dam+ supercompetent E.coli, only template DNA was degraded, leaving the 
chimeric mutant DNA as the only intact plasmid in the product. 
 After PCR product DNA was digested with dpn1, restriction profiling in the same fashion 
as the restriction and ligation protocol was performed on a subsequent gel (Figure 7). This gel 
yielded an approximately 4-5 kilobase vector fragment and a .1-.2 kilobase insert fragment, 
which matches the predicted size of the restricted fragments. After DNA was scaled up via mid-
sized culture and midiprep, a 1:100
th
 dilution of the DNA was analyzed in the UV-VIS DNA 
spec at wavelengths of 240 and 260 nm to determine its concentration so that it could be sent out 
for third-party sequencing to confirm the mutation of the DNA. DNA concentration in each 
sample was revealed to be .807 ng/μL, .916 ng/μL, and .206 ng/μL. As .2ng/μL dilution was 
needed, 20 μL of the lowest-concentration midiprep was removed for sequencing as it was 
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already in the appropriate concentration range. 
 Third-party DNA sequencing (Figure 1) revealed that a guanine was substituted for an 
adenine at position 121, indicating that sequence of the NES of the B isoform VP3 had 
successfully been imposed onto the PCV2A VP3 DNA. 
 After the generation of the chimeric protein was confirmed, the construct was transfected 
into the H1299 cell line to determine both apoptotic capacity via a caspase assay and the 
localization of the protein. The H1299 non-small lung cancer cell line was selected as a cell line 
for transfection due to its prior use in conjunction with CAV Apoptin homologs and its ease of 
maintenance. Localization studies may confer some kind of mechanistic information regarding 
the protein in conjunction with apoptosis data. 
 Transfection after plating at 40% confluence was confirmed by expression of GFP by 
epifluorescence microscopy; all successful transfectants were visibly green under microscope. 
The wild type transfections occurred at such low efficiency that they were rendered as non-DNA 
transfection controls, possibly due to low initial concentration from the stock DNA. These 
controls underwent the same chemical treatment as the other transfectants. Apoptosis of cells 
was established visually (Figure 2, E and F) in cells infected with the chimeric protein. Cell 
membrane integrity was visibly lowered, with sections beginning to compartmentalize and bud 
off of the main membrane. The localization appeared to be predominantly cytoplasmic, with the 
nuclear region expressing less GFP and chimeric protein. Some multimerization capability was 
also observed as the occasional bright points of concentration of GFP. Previous studies have 
speculated that multimerization capability in CAV Apoptin homologs may be associated with 
apoptotic ability. Quantification of the fraction of apoptotic cells was unreliable due to the 
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rounded physiology of the other cells which may have also been in the process of apoptosis or 
necrosis; differentiating between non-apoptotic cells and apoptotic cells would be disingenuous. 
A caspase-based apoptosis assay was performed in order to quantify apoptosis. During 
the process of apoptosis, effector caspases initiate a series of metabolic changes in the cell that 
lead to apoptosis. The apoptosis assay takes advantage of this by substituting endogenous 
caspase substrate with a caspase substrate which is conjugated to a fluorophore. Upon cleavage 
of the fluorophore with a caspase, the compound fluoresces strongly, which can be detected by 
fluorometry. Subsequent flurometry after incubation of the caspase assay reagents indicated that 
the chimeric protein, the ANES, and ANLS all had some measure of apoptotic capability (Figure 
9) as indicated by the high absorbance values at 520 nm compared to the transfection controls. 
Background fluorescence from GFP was negligible.  
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Discussion: 
 In this study we showed that a chimeric protein construct featuring the putative nuclear 
export sequence of PCV2b and the functional localization sequence of PCV2a possesses 
apoptotic killing ability in transformed cells of the H1299 lung cancer cell line. In addition to 
this, we observed through microscopic imaging that the localization of the chimera is consistent 
with that of both wild-type forms.  
 Transfection of H1299 cells with the GFP-fusion chimeric constructs and subsequent 
apoptosis assays measured using fluorometry confirmed killing ability, as seen in Figure 8. This 
may suggest that PCV2b isoform’s putative nuclear export sequence is largely responsible for 
induction of apoptosis in transformed cells. PCV2a was able to induce apoptosis with only the 
nuclear export sequence from the virulent isoform, and not the functional nuclear localization 
sequence. 
 Future analysis that includes quantitative data regarding the extent of apoptosis induction 
in the chimera versus wild-type PCV2b VP3 may help to further pinpoint the components of 
PCV2b VP3 responsible for its killing ability. Although the chimeric protein did show the ability 
to induce apoptosis in transformed cells, the degree of killing ability in the chimera versus the 
wild-type PCV2b VP3 has not yet been explored. If wild-type PCV2b were to display greater 
killing ability than the chimera, that may lead to speculation that the extent to which PCV2b is 
virulent depends in part on its nuclear export sequence and in part on its localization sequence. 
The same idea could apply to investigation of a chimeric protein construct featuring PCV2b’s 
localization sequence with PCV2a’s export sequence. 
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As previous research shows, PCV2a does not display killing ability in transformed cells. 
In addition to the above speculation regarding the nuclear export sequence of the b isoform, it 
may also be speculated under the current research that PCV2a shows no killing ability due to 
self-inhibition. Interestingly, our research may suggest that it is PCV2a VP3’s structure that 
accounts for its inability to induce apoptosis in transformed cells. Replacing the aromatic 
phenylalanine in PCV2a’s nuclear export sequence with the aliphatic leucine of PCV2b VP3 
may be responsible for altering possible structural inhibition of wild-type PCV2a VP3. Further 
research that aims to structurally alter wild-type PCV2b VP3 may provide more insight on this 
possibility. 
Our experimental transfections expressing truncations of PCV2a in H1299 cells further 
suggest that PCV2a inhibits itself from apoptotic ability structurally. One truncation included 
PCV2a’s nuclear localization sequence while the other truncation featured PCV2a’s nuclear 
export sequence. Figure 8 shows that fluorometric analysis of apoptotic assays measured 
increased caspase activity characteristic of apoptosis in the cells transfected with both 
truncations. This, again, leads to speculation that the apoptosis-inducing ability of both isoforms 
of PCV2 may lie in the protein’s structure, and not necessarily its specific nuclear export ability 
or its specific localization within the cells. 
Analysis of the chimeric localization in transfected cells coincided with wild-type 
localization patterns. However, as figure 8 demonstrates, visual results were somewhat 
inconclusive, as precise determination of the protein’s localization was made ambiguous. The 
raised, spherical nature of the transfected cells due to beginning stages of apoptosis complicated 
the focusing of the image. While this characteristic rendered exact localization inconclusive, it 
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served as a visual confirmation prior to any apoptosis assay that the chimera was fully capable of 
inducing apoptosis.  
Further investigation and revealing of the specific mechanism behind PCV2 VP3’s 
apoptosis-inducing ability in transformed cells will be of great value to the medical field. With a 
considerable degree of homology between CAV Apoptin and PCV2 VP3, both hold potential for 
applications in anti-cancer therapeutic drugs. The more that is understood about the functional 
mechanisms of one, the more is understood about the other.  
  
 21 
 
 
 
Figure 1. Site-directed mutagenesis introduces gain-of-function mutation in PCV2a VP3. Overlap-
extension PCR introduces a mutation into the template PCV2a DNA which causes its NES to match that 
of PCV2b.  
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A B   
C  D   
E   F  
Figure 2. Epifluorescence imaging of various PCV2 VP3 mutants fused to GFP vector. Shown are NES 
and NLS  truncation mutants (A,B), our chimeric mutant (C,D), and cells undergoing apoptosis after 
infection with our chimeric mutant (E,F). 
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Figure 3, schematic representation of the restriction digestion and ligation protocol. The NES and NLS of 
the respective isoforms will be cut and swapped to generate chimeric mutants which will then be analyzed 
for apoptotic capability. 
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Figure 4, restriction profile of GFP-PCV2 constructs. Second through fourth lanes represent restricted 
GFP-PCV2A-VP3 DNA; fourth through seventh represent GFP-PCV2B DNA, last two lanes represent 
control restrictions lacking SacII or EcoRI respectively. Vector fragment (top band) resides between the 5 
and 4 kilobase position markers on the ladder, while the insert fragment resides between the .1-.2 kilobase 
marker. The size of these fragments match the predicted 4.8 kilobase vector and 130 base insert fragment 
that should result from successful restriction at the SacII and EcoRI recognition sites. 
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Figure 5, synthesized mutagenic primer sequences. These sequences match the sequence and reverse 
complement of the NES of PCV2b VP3.When the DNA strands of the GFP PCV2a VP3 construct are 
melted apart, these primers will anneal to the appropriate complement. When Pfu Turbo polymerase 
extends these primers, the resultant daughter DNA will be the chimeric mutant. 
  
Forward Primer 
CCCACAATGACGTGTACATTAGTCTTCCAATCACGCTTCT 
_______________________________________________ 
Reverse Primer 
AGAAGCGTGATTGGAAGACTAATGTACACGTCATTGTGG 
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Figure 6, PCR Product gel. Top bands reside at around 4-5 kilobases, which is appropriately sized for the 
GFP PCV2VP3 construct, which is 5 kilobases in size. Bands at the bottom are likely digested template 
and leftover primer, corroborated by size around .1 kilobases. 
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Figure 7, gel following midiprep and restriction. Top bands lie around 4-5 kilobases, while insert 
fragments are approximately 1-2 kilobases in length, confirming that PCR generated and amplified the 
mutant GFP PCV2 VP3 chimera.  The size of the fragments predicted by restriction are 4.8 kilobases and 
130 bases. 
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Figure 8, caspase apoptosis assay. The chimeric protein exhibited apoptotic capacity  
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Figure 9, site-directed mutagenesis schematic. 
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